pubmed-article:1952814 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0015780 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0027368 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0005885 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0026832 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0002744 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0597299 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C1512045 | lld:lifeskim |
pubmed-article:1952814 | lifeskim:mentions | umls-concept:C0115134 | lld:lifeskim |
pubmed-article:1952814 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1952814 | pubmed:dateCreated | 1991-11-27 | lld:pubmed |
pubmed-article:1952814 | pubmed:abstractText | The effects of three doses (1, 4 and 10 mg/kg body weight) of an anabolic steroid, nandrolone phenylpropionate (NPP), on body weight and composition, and muscle protein metabolism were investigated in female rats. Daily injections of 1 mg/kg of NPP for 10 days caused a significant increase in weight gain which was associated with an increase in body protein (9%) without affecting body fat. At higher doses this effect on body weight was attenuated, resulting in no change in body weight at 10 mg/kg. However body protein content was still increased (9%) whereas body fat content was significantly reduced (32%). NPP did not affect metabolizable energy intake at any dose tested. Body energy gain and gross energetic efficiency were both significantly reduced in animals treated with a dose of 10 mg/kg. The mass and protein content of gastrocnemius muscle were significantly increased in animals injected with NPP at all doses. Muscle protein synthesis measured in vivo was also significantly stimulated at 1 and 4 mg/kg but was not affected at 10 mg/kg. These data confirm an anabolic action of NPP and suggest highly dose-dependent effects on other parameters such as body weight, fat deposition and muscle protein synthesis. | lld:pubmed |
pubmed-article:1952814 | pubmed:language | eng | lld:pubmed |
pubmed-article:1952814 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1952814 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1952814 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1952814 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1952814 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1952814 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1952814 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1952814 | pubmed:issn | 0250-6807 | lld:pubmed |
pubmed-article:1952814 | pubmed:author | pubmed-author:RothwellN JNJ | lld:pubmed |
pubmed-article:1952814 | pubmed:author | pubmed-author:ChouJ PJP | lld:pubmed |
pubmed-article:1952814 | pubmed:author | pubmed-author:EmeryP WPW | lld:pubmed |
pubmed-article:1952814 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1952814 | pubmed:volume | 35 | lld:pubmed |
pubmed-article:1952814 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1952814 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1952814 | pubmed:pagination | 141-7 | lld:pubmed |
pubmed-article:1952814 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:meshHeading | pubmed-meshheading:1952814-... | lld:pubmed |
pubmed-article:1952814 | pubmed:year | 1991 | lld:pubmed |
pubmed-article:1952814 | pubmed:articleTitle | Dose-dependent effects of an anabolic steroid, nandrolone phenylpropionate (Durabolin), on body composition and muscle protein metabolism in female rats. | lld:pubmed |
pubmed-article:1952814 | pubmed:affiliation | Department of Nutrition, King's College, London, UK. | lld:pubmed |
pubmed-article:1952814 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1952814 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1952814 | lld:pubmed |